Q4 2025 Holdings
Filed 2026-02-12 | 40 holdings | $177.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $15.6M | 225,000 | 8.8% |
| Medline Inc(MDLN) | COM CL A | 58507V107 | $12.6M | 300,000 | 7.1% |
| Sofi Technologies Inc(SOFI) | COM | 83406F102 | $10.5M | 400,000 | 5.9% |
| UL Solutions Inc(ULS) | CLASS A COM SHS | 903731107 | $10.3M | 130,000 | 5.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $8.7M | 50,000 | 4.9% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $8.0M | 197,313 | 4.5% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $7.8M | 100,000 | 4.4% |
| Miami Intl Hldgs Inc(MIAX) | COM | 59356Q108 | $7.8M | 175,000 | 4.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $7.6M | 100,000 | 4.3% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $7.6M | 1,349,771 | 4.3% |
| Legence Corp(LGN) | CL A | 52476L109 | $5.9M | 137,940 | 3.3% |
| Immunome Inc(IMNM) | COM | 45257U108 | $5.9M | 274,861 | 3.3% |
| ITT Inc(ITT) | COM | 45073V108 | $5.6M | 32,067 | 3.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $5.4M | 1,000,000 | 3.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.8M | 75,000 | 2.7% |
| Wealthfront Corp(WLTH) | COM | 947002101 | $4.1M | 300,000 | 2.3% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $4.0M | 94,134 | 2.2% |
| Southern Co(SOMN) | UNIT 12/15/2028 | 842587842 | $3.8M | 75,877 | 2.2% |
| ADT Inc del(ADT) | COM | 00090Q103 | $3.2M | 400,000 | 1.8% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $3.1M | 183,239 | 1.8% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $3.1M | 1,000,000 | 1.7% |
| Novanta Inc | UNIT 11/01/2028 | 67000B203 | $3.1M | 55,962 | 1.7% |
| Lumexa Imaging Holdings Inc(LMRI) | COM | 550249106 | $2.8M | 150,000 | 1.6% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $2.7M | 295,000 | 1.5% |
| Ambiq Micro Inc(AMBQ) | COMMON STOCK | 023193105 | $2.4M | 85,089 | 1.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $2.2M | 114,525 | 1.3% |
| Whitefiber Inc(WYFI) | SHS | G96115103 | $2.2M | 140,000 | 1.2% |
| Grupo Aeromexico SAB de CV(AERO) | SPONSORED ADS | 40054J109 | $2.0M | 91,619 | 1.1% |
| EQV Ventures AC Corp. II | UNIT 06/30/2032 | G3106Q110 | $2.0M | 198,313 | 1.1% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $1.8M | 195,000 | 1.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $1.7M | 160,336 | 0.9% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $1.6M | 137,430 | 0.9% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $1.5M | 91,620 | 0.9% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $1.3M | $1,874,000 | 0.7% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $1.2M | 22,905 | 0.7% |
| Lightpath Technologies Inc(LPTH) | COM CL A | 532257805 | $1.1M | 100,000 | 0.6% |
| Biodesix Inc(BDSX) | COM | 09075X207 | $763.9K | 112,344 | 0.4% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $666.3K | 125,000 | 0.4% |
| Imagenebio Inc(IMA) | COM | 45175G207 | $632.2K | 91,621 | 0.4% |
| Ibio Inc(IBIO) | COM NEW | 451033708 | $530.5K | 274,862 | 0.3% |